Back to Journals » Clinical Interventions in Aging » Volume 12

Five-year durability of stand-alone interspinous process decompression for lumbar spinal stenosis

Authors Nunley PD, Patel VV, Orndorff DG, Lavelle WF, Block JE, Geisler FH

Received 8 June 2017

Accepted for publication 18 July 2017

Published 6 September 2017 Volume 2017:12 Pages 1409—1417

DOI https://doi.org/10.2147/CIA.S143503

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Akshita Wason

Peer reviewer comments 2

Editor who approved publication: Dr Richard Walker

Pierce D Nunley,1 Vikas V Patel,2 Douglas G Orndorff,3 William F Lavelle,4 Jon E Block,5 Fred H Geisler6

1Spine Institute of Louisiana, Shreveport, LA, 2The Spine Center, University of Colorado Hospital, Denver, CO, 3Spine Colorado, Mercy Regional Hospital, Durango, CO, 4Upstate Bone and Joint Center, East Syracuse, NY, 5Independent Consultant, San Francisco, CA, 6Independent Consultant, Chicago, IL, USA

Background: Lumbar spinal stenosis is the most common indication for spine surgery in older adults. Interspinous process decompression (IPD) using a stand-alone spacer that functions as an extension blocker offers a minimally invasive treatment option for intermittent neurogenic claudication associated with spinal stenosis.
Methods: This study evaluated the 5-year clinical outcomes for IPD (Superion®) from a randomized controlled US Food and Drug Administration (FDA) noninferiority trial. Outcomes included Zurich Claudication Questionnaire (ZCQ) symptom severity (ss), physical function (pf), and patient satisfaction (ps) subdomains, leg and back pain visual analog scale (VAS), and Oswestry Disability Index (ODI).
Results: At 5 years, 84% of patients (74 of 88) demonstrated clinical success on at least two of three ZCQ domains. Individual ZCQ domain success rates were 75% (66 of 88), 81% (71 of 88), and 90% (79 of 88) for ZCQss, ZCQpf, and ZCQps, respectively. Leg and back pain success rates were 80% (68 of 85) and 65% (55 of 85), respectively, and the success rate for ODI was 65% (57 of 88). Percentage improvements over baseline were 42%, 39%, 75%, 66%, and 58% for ZCQss, ZCQpf, leg and back pain VAS, and ODI, respectively (all P<0.001). Within-group effect sizes were classified as very large for four of five clinical outcomes (ie, >1.0; all P<0.0001). Seventy-five percent of IPD patients were free from reoperation, revision, or supplemental fixation at their index level at 5 years.
Conclusion: After 5 years of follow-up, IPD with a stand-alone spacer provides sustained clinical benefit.

Keywords: interspinous spacer, lumbar spinal stenosis, Superion, neurogenic claudication, decompression
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Vacuum-assisted cesarean section

McQuivey RW, Block JE

International Journal of Women's Health 2017, 9:151-155

Published Date: 7 March 2017

Superion® InterSpinous Spacer for treatment of moderate degenerative lumbar spinal stenosis: durable three-year results of a randomized controlled trial

Patel VV, Nunley PD, Whang PG, Haley TR, Bradley WD, Davis RP, Block JE, Geisler FH

Journal of Pain Research 2015, 8:657-662

Published Date: 3 October 2015

Facial fat grafting with a prototype injection control device

Hetherington HE, Block JE

Clinical, Cosmetic and Investigational Dermatology 2013, 6:201-209

Published Date: 13 September 2013

Axial lumbar interbody fusion: a 6-year single-center experience

Zeilstra DJ, Miller LE, Block JE

Clinical Interventions in Aging 2013, 8:1063-1069

Published Date: 12 August 2013

TranS1 VEO system: a novel psoas-sparing device for transpsoas lumbar interbody fusion

Hardenbrook MA, Miller LE, Block JE

Medical Devices: Evidence and Research 2013, 6:91-95

Published Date: 4 June 2013

The KineSpring® Knee Implant System: an implantable joint-unloading prosthesis for treatment of medial knee osteoarthritis

Clifford AG, Gabriel SM, O’ Connell M, Lowe D, Miller LE, Block JE

Medical Devices: Evidence and Research 2013, 6:69-76

Published Date: 17 May 2013

Successful two-stage revision of a KineSpring® joint unloading implant: a case study

Bowditch M, Miller LE, Block JE

International Medical Case Reports Journal 2012, 5:91-95

Published Date: 12 December 2012

Facet-sparing lumbar decompression with a minimally invasive flexible MicroBlade Shaver® versus traditional decompression: quantitative radiographic assessment

Lauryssen C, Berven S, Mimran R, Summa C, Sheinberg M, Miller LE, Block JE

Clinical Interventions in Aging 2012, 7:257-266

Published Date: 20 July 2012

Rationale, characteristics, and clinical performance of the OsteoSponge®: a novel allograft for treatment of osseous defects

Miller LE, Jacofsky DJ, Kirker KR, Fitzpatrick KL, Juda GA, Block JE

Orthopedic Research and Reviews 2012, 4:9-17

Published Date: 3 April 2012

Clinical utility of ultrasound guidance for intra-articular knee injections: a review

Berkoff DJ, Miller LE, Block JE

Clinical Interventions in Aging 2012, 7:89-95

Published Date: 20 March 2012

Percutaneous vertebral augmentation for painful osteolytic vertebral metastasis: a case report

Anselmetti GC, Tutton SM, Facchini FR, Miller LE, Block JE

International Medical Case Reports Journal 2012, 5:13-17

Published Date: 20 March 2012